Changes in the management group

Report this content

Episurf Medical AB (Nasdaq: EPIS B) today announces that effective as of February 1st 2021, Michael Näsström has been appointed as Head of Quality and Regulatory Affairs and will take part in the Management Group of Episurf Medical. Michael is currently serving as Quality Manager in the company. 

“Michael has been instrumental in Episurf Medical during the last years, and I would like to congratulate him on his new role,” says Pål Ryfors, CEO Episurf Medical. 

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: